Φορτώνει......
Suvorexant: a promising, novel treatment for insomnia
Suvorexant a novel, orexin receptor antagonist was recently approved by the US Food and Drug Administration for the treatment of sleep onset and sleep maintenance insomnia in August 2014. Multiple animal and human studies support the efficacy, safety, and tolerability of suvorexant for patients of v...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Neuropsychiatr Dis Treat |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772996/ https://ncbi.nlm.nih.gov/pubmed/26955275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S31495 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|